CELLOPHIL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

CELLOPHIL Trademark

Serial Number: 79105220 • Registration: 4326294

CELLOPHIL is a trademark filed by CIS Pharma - Chemisches Institut Schäfer AG on July 22, 2011. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 24 (Fabrics). The application is currently registered and active.

Owner Contact Info

CIS Pharma - Chemisches Institut Schäfer AG

Hauptstrasse 159

Entity Type: 99

Trademark Details

Filing Date

July 22, 2011

Registration Date

April 30, 2013

Published for Opposition

February 12, 2013

Cancellation Date

July 22, 2021

Goods & Services

Optical apparatus, namely, contact lenses and corneal contact lenses composed of polymers; contact lenses

Pharmaceutical products, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, namely, drug loaded polymers and thermoresponsive polymers for use as sustained release systems containing pharmaceutical compounds for human diseases, anti-infective pharmaceuticals, cardiovascular pharmaceuticals, ocular pharmaceuticals, cytotoxic pharmaceuticals, CNS pharmaceuticals, pharmaceutical preparations for the treatment of age-related macular degeneration, diabetic retinopathy, uveitis, inner ocular pressure, gout, heart rhythm disorders, infectious diseases, liver diseases, kidney diseases, respiratory diseases, gastro-intestinal diseases, brain diseases, bone marrow diseases, diabetes, hypertension, tumours, bone regeneration, tissue regeneration, injuries; veterinary products, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of veterinary pharmaceuticals, namely, drug loaded polymers containing pharmaceutical compounds for veterinary diseases, anti-infective products for veterinary use, veterinary vaccines, pharmaceutical reagents for veterinary purposes, veterinary preparations for mammalian animals to treat diseases such as, but not limited to hypertension, tumours, cardiovascular diseases, injuries; sanitary products for medical purposes, namely, chemical preparations for sanitary purposes, sanitary preparations for medical use, sanitary sterilizing preparations; materials for medical dressings, namely, thermoresponsive polymers and drug loaded thermoresponsive polymers for dressings; material for dental bone fillings, dental fillings, and dental impressions

Textiles and textile goods, namely, textile fabrics for the manufacture of clothing, textile fabrics for outdoor furnishings and for home and commercial interiors

Chemicals for use in industry and science, namely, polymers; unprocessed artificial resins, unprocessed plastics

Surgical apparatus and instruments; medical, dental, and veterinary apparatus, namely, artificial heart valves, stents, stents in the nature of bypasses, artificial blood vessels for treating cardiovascular diseases, catheters, coated artificial bone and dental implants, artificial limbs and eyes, artificial substitutes for tendons, cellular matrices for organ specific cell-replacement, namely, implantable scaffolds comprising artificial materials for maintaining tissue contour; orthopedic articles, namely, polymer coated orthopedic joint implants, orthopedic support bandages, orthopedic supports, vertebral orthopedic apparatus and artificial vertebral discs; suture materials

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 13, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Feb 13, 2022 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Oct 10, 2020 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Sep 12, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 12, 2020 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 6, 2020 INTR
CANCELLED SECTION 71
Dec 6, 2019 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 30, 2018 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 6, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 5, 2013 FICS
FINAL DISPOSITION PROCESSED
Aug 5, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Mar 4, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 12, 2013 NPUB
PUBLISHED FOR OPPOSITION
Feb 12, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 23, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 23, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 23, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 8, 2013 PREV
ASSIGNED TO LIE
Jan 7, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 17, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 15, 2012 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 15, 2012 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 20, 2012 GNFN
FINAL REFUSAL E-MAILED
Jun 20, 2012 GNFR
FINAL REFUSAL WRITTEN
Jun 20, 2012 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2012 CRFA
ASSIGNED TO LIE
May 18, 2012 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 8, 2012 TROA
REFUSAL PROCESSED BY IB
Dec 31, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 9, 2011 RFCS
REFUSAL PROCESSED BY MPU
Dec 8, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 8, 2011 RFCR
APPLICATION FILING RECEIPT MAILED
Dec 8, 2011 MAFR
NON-FINAL ACTION WRITTEN
Dec 7, 2011 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 4, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 1, 2011 REPR